These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 4397889)
1. Utilization of ammonium ions for purine precursor synthesis in soluble extracts of Ehrlich ascites cells. Trachewsky D; Johnstone RM Can J Biochem; 1969 Sep; 47(9):839-45. PubMed ID: 4397889 [No Abstract] [Full Text] [Related]
2. Allopurinol and oxipurinol: alteration of purine and pyrimidine metabolism in cell culture. Kelley WN; Fox IH; Beardmore TD; Meade JC Ann N Y Acad Sci; 1971 Jul; 179():588-95. PubMed ID: 4328264 [No Abstract] [Full Text] [Related]
3. Pharmacologic regulation of the early steps of purine biosynthesis in Burkitt lymphoma cells and in Ehrlich ascites tumor cells. Reem GH J Pharmacol Exp Ther; 1974 Oct; 191(1):1-9. PubMed ID: 4371231 [No Abstract] [Full Text] [Related]
4. Fluorinated pyrimidine aldehydes. Inhibition of nucleic acid and protein biosynthesis in Ehrlich ascites carcinoma cells in vitro. Chae CB; Irvin JL; Piantadosi C J Med Chem; 1968 May; 11(3):506-13. PubMed ID: 5656488 [No Abstract] [Full Text] [Related]
5. Effects of diazoacetyl-glycine amide on purine nucleotide and deoxyribonucleic acid synthesis in Ehrlich ascites tumor cells. Giraldi T; Steppani G; Baldini L Biochem Pharmacol; 1972 Nov; 21(22):3035-9. PubMed ID: 4649352 [No Abstract] [Full Text] [Related]
6. Inhibition of purine biosynthesis de novo and of Ehrlich ascites tumor cell growth by 6-methylmercaptopurine ribonucleoside. Shantz GD; Fontenelle LJ; Henderson JF Biochem Pharmacol; 1972 Apr; 21(8):1203-6. PubMed ID: 5034201 [No Abstract] [Full Text] [Related]
7. Sources of nitrogen as rate-limiting factors for purine biosynthesis de novo in Ehrlich ascites tumor cells. Fontenelle LJ; Henderson JF Biochim Biophys Acta; 1969 Feb; 177(1):88-93. PubMed ID: 4305525 [No Abstract] [Full Text] [Related]
8. [Metabolism of nitrogen in Ehrlich ascites tumor cells: role of glutamine and ammonium]. Carrascosa JM; Martínez P; Núñez de Castro I Rev Esp Oncol; 1983; 30(4):533-7. PubMed ID: 6599917 [TBL] [Abstract][Full Text] [Related]
9. Decreased feedback inhibition in a 6-(methylmercapto)purine ribonucleoside-resistant tumor. Henderson JF; Caldwell IC; Paterson AR Cancer Res; 1967 Oct; 27(10):1773-8. PubMed ID: 6064956 [No Abstract] [Full Text] [Related]
10. Purine metabolism in the chick embryo; effects of uricogenesis and xanthine oxidase inhibition. Duggan DE; Pua KH; Elfenbein G Mol Pharmacol; 1968 Jan; 4(1):53-60. PubMed ID: 5640779 [No Abstract] [Full Text] [Related]
11. Rate-limiting steps in the interconversion of purine ribonucleotides in Ehrlich ascites tumor cells in vitro. Crabtree GW; Henderson JF Cancer Res; 1971 Jul; 31(7):985-91. PubMed ID: 5560389 [No Abstract] [Full Text] [Related]
12. Inhibition of purine ribonucleotide and phosphoribosyl pyrophosphate synthesis by 6-cyclopentylthio-9-hydroxymethylpurine and structurally related compounds. Smith CM; Fontenelle LJ; Lalanne M; Henderson JF Cancer Res; 1974 Mar; 34(3):463-7. PubMed ID: 4359876 [No Abstract] [Full Text] [Related]